Tuesday, May 21, 2013
image image
Monday, July 16, 2012

22 of America’s Most Promising Scientists Selected as Pew Biomedical Scholars

Salil A. Lachke
Salil A. Lachke
Sohini Ramachandran
Sohini Ramachandran
PHILADELPHIA-- Twenty-two of the nation's most innovative young researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts on June 14. 

The Scholars join a prestigious community that includes Nobel Prize winners, MacArthur Fellows, and recipients of the Albert Lasker Medical Research Award.   

The new class of scholars is exploring a range of human health issues from antibiotic-resistant infections to liver disease and cancer. 

The new Indian American 2012 Pew Scholars are:

Salil A. Lachke, Ph.D.

University of Delaware
Developmental Genetics

Sohini Ramachandran, Ph.D.
Brown University 
Human Genomics and Evolution

Launched in 1985, the Pew Scholars Program in the Biomedical Sciences identifies and invests in talented researchers in medicine or biomedical sciences. In that time, over 500 Pew Scholars have received more than $130 million in funding. By backing them early in their careers, this program enables our most promising scientists to take calculated risks and follow unanticipated leads to advance human health.

The program is rigorously competitive, and recipients receive $240,000 over four years to pursue their research without restriction. To be considered, applicants from all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 179 institutions were requested to nominate a candidate, and 134 eligible nominations were received.

The initiative is run by The Pew Charitable Trusts, which also directs the Pew Latin American Fellows in the Biomedical Sciences, a program that for 21 years has provided support for young scientists fromLatin America to receive postdoctoral training in the United States.

Print Friendly Version

(Permalink)

Commenting is not available in this weblog entry.